TAF1-dependent transcriptional dysregulation underlies multiple sclerosis
Claudia Rodríguez-López, Ivó H. Hernández, José Terrón-Bautista, Eneritz Agirre, Julia Pose‐Utrilla, David Lozano-Muñoz, Irene Ruiz-Blas, Alejandra M. Arroyo, Inés García-Ortiz, Miriam Lucas-Santamaría, María González-Bermejo, María Cristina Ortega, Isabel Machín-Díaz, Juan Carlos Chara, Tjado H.J. Morrema, , José J. Lucas
This study identifies TAF1-dependent transcriptional dysregulation as a mechanism underlying multiple sclerosis progression and presents an in vivo model for therapeutic development.
bioRxiv · Aug 23, 2024 · PreprintNeuroscience